New Equilibrium Biosciences
Drug discovery for intrinsically disordered proteins.
Launch date
Employees
Market cap
-
Enterprise valuation
€36—55m (Dealroom.co estimates Mar 2021.)
Boston Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$350k | Grant | ||
$250k | Seed | ||
$10.0m | Seed | ||
| Total Funding | €9.6m | ||
Related Content
Recent News about New Equilibrium Biosciences
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.